PT - JOURNAL ARTICLE AU - Harvey A. Ziessman TI - Hepatobiliary Scintigraphy in 2014 AID - 10.2967/jnumed.113.131490 DP - 2014 Dec 01 TA - Journal of Nuclear Medicine Technology PG - 249--259 VI - 42 IP - 4 4099 - http://tech.snmjournals.org/content/42/4/249.short 4100 - http://tech.snmjournals.org/content/42/4/249.full SO - J. Nucl. Med. Technol.2014 Dec 01; 42 AB - Cholescintigraphy with 99mTc-hepatobiliary radiopharmaceuticals has been an important, clinically useful diagnostic imaging study for almost 4 decades. It continues to be in much clinical demand; however, the indications, methodology, and interpretative criteria have evolved over the years. This review will emphasize state-of-the-art methodology and diagnostic criteria for various clinical indications, including acute cholecystitis, chronic acalculous gallbladder disease, high-grade and partial biliary obstruction, and the postcholecystectomy pain syndrome, including sphincter-of-Oddi dysfunction and biliary atresia. The review will also emphasize the use of diagnostic pharmacologic interventions, particularly sincalide.